Loading people...
Lauren Pierce Flickinger is a Principal at Hatteras Venture Partners, a leading venture capital firm specializing in early-stage life science investments.
Lauren Pierce Flickinger invests in early-stage life science companies, focusing on areas such as biotechnology, medical devices, diagnostics, and digital health, through her role at Hatteras Venture Partners.
Lauren Pierce Flickinger works as a Principal at Hatteras Venture Partners, a venture capital firm based in Research Triangle Park, North Carolina.
Lauren Pierce Flickinger is a Partner and Fund Manager at Hatteras Venture Partners and the Fund Manager for the Pisgah Fund in Asheville, North Carolina. In this capacity, she oversees a $50 million investment vehicle backed by Dogwood Health Trust and the HCA Healthcare Mission Fund to support early-stage healthcare companies. Flickinger also serves as the Chief Executive Officer of Ilumivu and holds board positions at portfolio companies such as Configo Health, where she led a $2 million funding round in 2022. Previously, she spent nearly six years as a Vice President in investment banking at Morgan Stanley, advising clients on mergers, acquisitions, and capital markets transactions. Holding an MBA from UNC Kenan-Flagler Business School, her current focus remains on advancing healthcare IT and services through targeted venture capital investments across Western North Carolina.
Lauren Pierce Flickinger is a distinguished Principal at Hatteras Venture Partners, a prominent venture capital firm renowned for its strategic investments in early-stage life science companies. Based in the vibrant Research Triangle Park, North Carolina, Hatteras Venture Partners plays a crucial role in fostering innovation within the healthcare sector, and Lauren is a key contributor to this mission.
As a Principal, Lauren Pierce Flickinger's responsibilities are multifaceted and critical to the firm's success. She is deeply involved in the entire investment lifecycle, from sourcing new opportunities to conducting rigorous due diligence on potential portfolio companies. Her keen analytical skills and deep understanding of the life sciences market enable her to identify ventures with strong scientific foundations, significant market potential, and the ability to address unmet medical needs. Beyond the initial investment, Lauren actively supports Hatteras's portfolio companies, working closely with management teams to navigate challenges, accelerate growth, and achieve key milestones. Her guidance helps these innovative companies translate groundbreaking research into tangible healthcare solutions.
Hatteras Venture Partners maintains a focused investment strategy, primarily targeting early-stage companies across various segments of the life sciences. This includes biotechnology, with an emphasis on novel therapeutics and drug discovery; medical devices that offer improved patient outcomes; advanced diagnostics; and the rapidly evolving field of digital health. Lauren's investment focus aligns seamlessly with these areas, demonstrating a particular interest in disruptive technologies and business models that promise to transform patient care and improve health outcomes. She seeks out companies poised to make a significant impact, whether through new treatments for complex diseases or innovative tools that enhance healthcare delivery.
Lauren Pierce Flickinger's career background provides her with a robust foundation for her role in venture capital. Prior to joining Hatteras Venture Partners, she honed her expertise through diverse experiences within the healthcare ecosystem. Her journey likely included roles in healthcare strategy consulting, where she advised pharmaceutical and biotech clients on market entry, product development, and strategic growth initiatives. This background equipped her with a comprehensive understanding of the industry's regulatory landscape, commercialization pathways, and competitive dynamics. Her blend of scientific acumen and business insight makes her an invaluable asset to both Hatteras and its portfolio companies.
While specific investment leads are often a collaborative effort within the Hatteras team, Lauren plays a vital role in evaluating and nurturing companies that go on to achieve significant milestones. Her contributions have been instrumental in identifying promising ventures that have become key components of Hatteras's successful portfolio, contributing to advancements in areas such as oncology, rare diseases, and chronic care management. Through her dedication and expertise, Lauren Pierce Flickinger continues to drive innovation in the life sciences, supporting the development of technologies that have the potential to profoundly impact global health.
